| pubmed-article:16842841 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16842841 | lifeskim:mentions | umls-concept:C2917212 | lld:lifeskim |
| pubmed-article:16842841 | lifeskim:mentions | umls-concept:C0010206 | lld:lifeskim |
| pubmed-article:16842841 | lifeskim:mentions | umls-concept:C0534191 | lld:lifeskim |
| pubmed-article:16842841 | lifeskim:mentions | umls-concept:C0072434 | lld:lifeskim |
| pubmed-article:16842841 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:16842841 | pubmed:dateCreated | 2007-3-2 | lld:pubmed |
| pubmed-article:16842841 | pubmed:abstractText | Prothrombin complex concentrate (PCC) is recommended for emergency reversal of oral coumarin anticoagulation. Recently, recombinant factor VIIa (rFVIIa) has also been investigated for this purpose, although no direct comparison of PCC and rFVIIa has been reported. This study was designed to compare the effectiveness of PCC and rFVIIa for reversal of both acute and sustained coumarin anticoagulation. | lld:pubmed |
| pubmed-article:16842841 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16842841 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16842841 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16842841 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16842841 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16842841 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16842841 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16842841 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16842841 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16842841 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16842841 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16842841 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16842841 | pubmed:issn | 0049-3848 | lld:pubmed |
| pubmed-article:16842841 | pubmed:author | pubmed-author:DickneiteGerh... | lld:pubmed |
| pubmed-article:16842841 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16842841 | pubmed:volume | 119 | lld:pubmed |
| pubmed-article:16842841 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16842841 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16842841 | pubmed:pagination | 643-51 | lld:pubmed |
| pubmed-article:16842841 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:16842841 | pubmed:meshHeading | pubmed-meshheading:16842841... | lld:pubmed |
| pubmed-article:16842841 | pubmed:meshHeading | pubmed-meshheading:16842841... | lld:pubmed |
| pubmed-article:16842841 | pubmed:meshHeading | pubmed-meshheading:16842841... | lld:pubmed |
| pubmed-article:16842841 | pubmed:meshHeading | pubmed-meshheading:16842841... | lld:pubmed |
| pubmed-article:16842841 | pubmed:meshHeading | pubmed-meshheading:16842841... | lld:pubmed |
| pubmed-article:16842841 | pubmed:meshHeading | pubmed-meshheading:16842841... | lld:pubmed |
| pubmed-article:16842841 | pubmed:meshHeading | pubmed-meshheading:16842841... | lld:pubmed |
| pubmed-article:16842841 | pubmed:meshHeading | pubmed-meshheading:16842841... | lld:pubmed |
| pubmed-article:16842841 | pubmed:meshHeading | pubmed-meshheading:16842841... | lld:pubmed |
| pubmed-article:16842841 | pubmed:meshHeading | pubmed-meshheading:16842841... | lld:pubmed |
| pubmed-article:16842841 | pubmed:meshHeading | pubmed-meshheading:16842841... | lld:pubmed |
| pubmed-article:16842841 | pubmed:meshHeading | pubmed-meshheading:16842841... | lld:pubmed |
| pubmed-article:16842841 | pubmed:meshHeading | pubmed-meshheading:16842841... | lld:pubmed |
| pubmed-article:16842841 | pubmed:meshHeading | pubmed-meshheading:16842841... | lld:pubmed |
| pubmed-article:16842841 | pubmed:meshHeading | pubmed-meshheading:16842841... | lld:pubmed |
| pubmed-article:16842841 | pubmed:meshHeading | pubmed-meshheading:16842841... | lld:pubmed |
| pubmed-article:16842841 | pubmed:meshHeading | pubmed-meshheading:16842841... | lld:pubmed |
| pubmed-article:16842841 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:16842841 | pubmed:articleTitle | Prothrombin complex concentrate versus recombinant factor VIIa for reversal of coumarin anticoagulation. | lld:pubmed |
| pubmed-article:16842841 | pubmed:affiliation | ZLB Behring GmbH, D-35002 Marburg, Germany. gerhard.dickneite@zlbbehring.com | lld:pubmed |
| pubmed-article:16842841 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16842841 | pubmed:publicationType | Comparative Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16842841 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16842841 | lld:pubmed |
